Open Orphan spin-out Poolbeg Pharma to list on London market

Company will use money from listing to meet costs for flu drug trials, develop assets

Open Orphan gets approval to reduce capital ahead of spin-out

Company says reduction of capital will allow it to return value to its shareholders

Open Orphan plans for possible spin-out of non-core assets

Company says HVO-001 could be included as part of potential demerger

Failure to reform State pension age could cost up to €50bn

Seen and Heard: Quinlan bankruptcy case set for June; Hammerson stuck for Ilac tenants

Open Orphan subsidiary wins €7.5m contract to run study

Contract with US biotechnology company concerns a respiratory syncytial virus

Open Orphan company successfully completes nasal spray study

Prophylactic spray could be used against Covid-19

Open Orphan renews contract with major pharma company

Dublin-listed pharmaceutical services company says new deal will run for another year

Open Orphan gets green light for Covid-19 nasal vaccine trial

Vaccine could be one of the first to provide long-term immunity from Covid-19

Venn Life Sciences wins another Covid-19 drug study

Open Orphan subsidiary to manage Phase 2 clinical trial for European pharma company

Open Orphan subsidiary takes lead role on guidelines for human challenge agents

Guidelines will cover manufacture of agents for use in controlled infection studies

Open Orphan signs two year contract with German pharma company

Contract guarantees annual revenue for Dublin listed company

Open Orphan subsidiary hVivo signs deal for Covid-19 challenge study

Contract with UK government could be worth up to £10m

Open Orphan eyes profitability as it reports £4.1m ebitda loss

Company led by Cathal Friel recorded revenues of £7.1m for its first half

Open Orphan wins contract to support European pharma giant

Paris subsidiary Venn Life Sciences to work with oncology study enrolling 750 subjects

EY Entrepreneur of the Year international finalists focusing on growth

Sectors include health and safety, pharma, crop protection and refrigeration

Open Orphan wins €4m contract to conduct trial for new RSV treatment

Dublin-listed pharmaceutical services company says contract is with top three pharma group

Open Orphan deal to generate ‘significant revenue’ for Venn Life Sciences

New contract with Japanese company Carna Bioscience follows close collaboration on drug development planning and pre-clinical activities

Open Orphan signs deal to carry out Covid-19 vaccine trial

Dublin listed company will carry out phase one trial at Hvivo facility

Open Orphan signs option to acquire company for ‘nominal sum’

The pharmaceutical company has three months to acquire CHIMagents

Open Orphan develops first challenge study model to test Covid-19 vaccines

Dublin-listed pharmaceutical services company publishes annual results for 2019

Open Orphan sees positive trial on mosquito-borne disesases

Company is developing a vaccine to guard against diseases such as malaria and zika

EY selects 24 finalists to battle for Entrepreneur of the Year award

Tech and life sciences businesses well represented in addition to traditional players

Open Orphan signs big deal with vaccine manufacturer

Agreement covers market access of newly developed medicine into EU and US markets

Open Orphan launches Covid-19 antibody testing service

London subsidiary Hvivo will carry out testing at its lab with 48-hour turnaround

Open Orphan raises €13.4m to ramp up Covid-19 study

Challenge study models could speed up the development of a vaccine by up to three years

Covid-19: Open Orphan to carry out 3,000 antibody tests per day

Antibody tests can detect if a person has had coronavirus before and has since recovered

Irish companies come out in force to help during Covid-19 pandemic

Issues with everything from drug trials to tech solutions, patient care are being tackled

Dublin-listed Open Orphan to test Covid-19 drug through London subsidiary

As many as 100 potential Covid-19 candidate vaccines are now under development by biotech and research teams around the world

Open Orphan seals deal that could net more than €11.6m

Dublin-listed pharma group announces contract with European biotech company

Open Orphan raises £5.3m through share placing

Drug consulting services platform to use proceeds to fund growth and synergies

Open Orphan to ‘boost revenue’ with new contract

Pharma services company to build on an existing relationship with German company

Open Orphan to merge with UK-based Hvivo in £30m tie-up

Deal values Hvivo at £12.96m, with its shareholders owning 44.7% of enlarged company

Open Orphan resumes trading on markets following merger

Company chief executive Cathal Friel says it has ‘a clear growth strategy’ for shareholders

Venn Life Sciences to pursue ‘build to sell’ plan after merger

Combined group to fall under Open Orphan name

Cathal Friel reverses Open Orphan into listed Venn Life Sciences

Clinical trials group issues profit warning alongside results ahead of merger

Venn signs deal with Open Orphan to focus on rare diseases

Company has issued €1.1m in loan notes to fund specialisation in orphan diseases

Caveat: Web Summit – different city, same old expense

Event moved due to high room rates in Dublin but Portuguese prices look similar

Fastnet shareholders back Amryt Pharma reverse takeover

All-cash deal for Fastnet also involved raising £10m (€12.5m) for future acquisitions

Cantillon: Fastnet chief explains switch to pharma

Fastnet Oil & Gas shareholders to be asked to approve reverse takeover by Amryt Pharma

Fastnet reports $1.5m loss, ready to assess healthcare targets

Dublin and London-listed firm recently completed demerger of oil and gas assets

YOU MAY ALSO LIKE...

Belfast Agreement

Explore how the historic deal helped bring about peace in Northern Ireland

The Irish Times ePaper

Stardust

Inquests into the nightclub fire that led to the deaths of 48 people

North & South

A project examining attitudes about the future of Ireland